| Mrs Penny Gauvin, LCPC | |
|
39 Limerick Rd, 6u, Arundel, ME 04046-8158 | |
| (207) 590-3668 | |
| (207) 467-3490 |
| Full Name | Mrs Penny Gauvin |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 39 Limerick Rd, Arundel, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437466430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | CC2445 (Maine) | Primary |
| Entity Name | Sweetser |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538122445 PECOS PAC ID: 8325946213 Enrollment ID: O20031230000339 |
News Archive
Orthovita, Inc., an orthobiologics and biosurgery company, reported today that the U.S. Food and Drug Administration (FDA) approved Orthovita's PMA supplement for a new collagen processing facility in Malvern, Pennsylvania. Orthovita will use the new facility to process the highly purified form of collagen used in its VITAGEL™ Surgical Hemostat product. VITAGEL is a composite liquid hemostat used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
According the Centers for Disease Control and Prevention, approximately 6 - 8% of pregnant women experience hypertension. High blood pressure during pregnancy is associated with a number of risks to the woman and fetus, including low-birth weight infants, preterm birth, problems with the placenta, heavy bleeding, heart defects and other congenital anomalies, and in the most severe cases death.
Researchers from Spain have analysed the prevalence of leishmaniasis among the population of organ transplant recipients. The findings of this study, published in the journal 'PLoS Neglected Tropical Disease', confirm that the risk of developing visceral leishmaniasis ‑the most severe form of the disease which can pose life-threatening complications‑ is more than one hundred times greater in transplant patients living in areas of disease outbreak.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Penny Gauvin, LCPC 12 Tibbetts Ln, Lyman, ME 04002-7572 Ph: (207) 590-3668 | Mrs Penny Gauvin, LCPC 39 Limerick Rd, 6u, Arundel, ME 04046-8158 Ph: (207) 590-3668 |
News Archive
Orthovita, Inc., an orthobiologics and biosurgery company, reported today that the U.S. Food and Drug Administration (FDA) approved Orthovita's PMA supplement for a new collagen processing facility in Malvern, Pennsylvania. Orthovita will use the new facility to process the highly purified form of collagen used in its VITAGEL™ Surgical Hemostat product. VITAGEL is a composite liquid hemostat used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
According the Centers for Disease Control and Prevention, approximately 6 - 8% of pregnant women experience hypertension. High blood pressure during pregnancy is associated with a number of risks to the woman and fetus, including low-birth weight infants, preterm birth, problems with the placenta, heavy bleeding, heart defects and other congenital anomalies, and in the most severe cases death.
Researchers from Spain have analysed the prevalence of leishmaniasis among the population of organ transplant recipients. The findings of this study, published in the journal 'PLoS Neglected Tropical Disease', confirm that the risk of developing visceral leishmaniasis ‑the most severe form of the disease which can pose life-threatening complications‑ is more than one hundred times greater in transplant patients living in areas of disease outbreak.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 2 days ago
Mr. Floyd Daniel Erickson, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 72 Macchipkay Rd, Arundel, ME 04046 Phone: 207-831-4125 |